Drug Shortage Report for RAN-DULOXETINE
Report ID | 127955 |
Drug Identification Number | 02438267 |
Brand name | RAN-DULOXETINE |
Common or Proper name | DULOXETINE |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | DULOXETINE |
Strength(s) | 60MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-01 |
Estimated end date | 2020-12-04 |
Actual end date | 2020-11-30 |
Shortage status | Resolved |
Updated date | 2020-12-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-12-03 | French | Compare |
v5 | 2020-12-03 | English | Compare |
v4 | 2020-12-03 | French | Compare |
v3 | 2020-12-03 | English | Compare |
v2 | 2020-11-06 | French | Compare |
v1 | 2020-11-06 | English | Compare |
Showing 1 to 6 of 6